Now, a study led by scientists at The Scripps Research Institute (TSRI) helps provide insight into these questions, showing that, in rat models, nicotine exposure actually promotes alcohol dependence.
“It’s a vicious cycle,” said TSRI biologist Olivier George, a senior author of the new study. “Nicotine makes individuals crave alcohol to ‘reward’ the brain and reduce stress.”
In the study, published April 14, 2015, in The Journal of Neuroscience, the researchers also showed that the combination of nicotine and alcohol activated a unique group of neurons, giving positive reinforcement to continue alcohol and nicotine use.
In conducting the new research, the team first tested whether nicotine exposure could affect alcohol-drinking behavior in rat models. They started with two groups of male rats. Both groups were given access to alcohol to establish the baseline of how much they would drink. The rats drank a little bit, perhaps the equivalent of one or two beers for a human, but they stopped before showing signs of drunkenness.
After this baseline test, the researchers used alcohol vapor to induce alcohol dependence in one group of rats. Dependence developed in about two months. In subsequent tests where alcohol was freely available, these rats consumed the equivalent of a six-pack of beer and had blood alcohol levels close to three times the legal limit for humans.
The second group of rats was exposed to both nicotine and alcohol vapor. These rats developed alcohol dependence much faster—and they began drinking the equivalent of a six-pack in just three weeks. “We had never seen such a rapid escalation of alcohol drinking before,” said George.
The researchers then offered the rats alcohol with the bitter compound quinine added to see if they could stop the rats from drinking. Most rats decreased their alcohol consumption to avoid the bitter taste, but the nicotine-exposed rats just kept drinking. This indicated that their behavior was compulsive, much like alcoholism in humans.
Using further neurological studies, George and his colleagues tracked this compulsive behavior to the activation of “stress” and “reward” pathways in the brain.
Previous studies from George’s lab had shown that nicotine activates certain “reward” neurons in the brain—giving positive reinforcement to keep smoking. At the same time, nicotine activates “stress” neurons in the brain, giving negative reinforcement. This stress can lead individuals to crave alcohol to both activate the reward system and calm the stress system.
The compulsive alcohol consumption and neurological pathways seen in the new study suggest that alcohol works with nicotine to further activate the brain’s reward system and dampen the stress of nicotine exposure.
This interaction may explain why it is difficult for smokers to quit drinking, and vice versa. Interestingly, the combination of neurons activated by nicotine and alcohol together is different from the neurons activated by each substance on its own.
“Now we can try to find compounds that will specifically inactivate those neurons,” said George.
In addition to George, other authors of the paper, “Chronic Nicotine Activates Stress/Reward-Related Brain Regions and Facilitates the Transition to Compulsive Alcohol Drinking,” were Fabio C. Cruz and Bruce T. Hope of the Behavioral Neurosciences Branch of Intramural Research Program of the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services (IRP/NIDA/NIH/DHHS); Leandro F. Vendruscolo, Giordano de Guglielmo and Marian L. Logrip of TSRI; George Koob of TSRI; and Rodrigo M. Leao of IRP/NIDA/NIH/DHHS, TSRI and the University of Estadual Paulista.
This research was supported by National Institutes of Health’s National Institute on Alcohol Abuse and Alcoholism (grants AA018914, AA020608, AA008459, AA006420 and DA023597) and a Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) PDEE fellowship.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world’s largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including two Nobel laureates—work toward their next discoveries. The institute’s graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
# # #
Office of Communications